5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

NCT03300609 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Insufficient Accrual

Conditions

Colorectal Adenocarcinoma
RAS Wild Type
Stage III Colorectal Cancer AJCC v7
Stage IIIA Colorectal Cancer AJCC v7
Stage IIIB Colorectal Cancer AJCC v7
Stage IIIC Colorectal Cancer AJCC v7
Stage IV Colorectal Cancer AJCC v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7

Interventions

BIOLOGICAL: Panitumumab
DRUG: Oxaliplatin
DRUG: Leucovorin Calcium
DRUG: Fluorouracil
DRUG: Capecitabine
OTHER: Quality-of-Life Assessment
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]